NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
2020 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction
Pascual-Figal, D.; Senni, M.; Bao, W.; Noè, A.; Schwende, H.; Butylin, D. & Prescott, M. F. et al. (2020)
JACC: Heart Failure, 8(10) pp. 822-833. DOI: https://doi.org/10.1016/j.jchf.2020.05.012
Documents & Media
Details
- Authors
- Pascual-Figal, Domingo; Senni, Michele; Bao, Weibin; Noè, Adele; Schwende, Heike; Butylin, Dmytro; Prescott, Margaret F.; Gniot, Jacek; Mozheiko, Maria; Karabsheh, Shadi; Wachter, Rolf
- Issue Date
- 2020
- Journal
- JACC: Heart Failure
- ISSN
- 2213-1779
- Language
- English
- Sponsor
- http://dx.doi.org/10.13039/100008349 Boehringer Ingelheim
http://dx.doi.org/10.13039/100004336 Novartis
http://dx.doi.org/10.13039/501100000780 European Commission
http://dx.doi.org/10.13039/100004339 Sanofi
http://dx.doi.org/10.13039/501100002347 Bundesministerium für Bildung und Forschung
http://dx.doi.org/10.13039/100004319 Pfizer
http://dx.doi.org/10.13039/501100011725 Servier
http://dx.doi.org/10.13039/100004326 Bayer
http://dx.doi.org/10.13039/100004374 Medtronic
